logo
[breadcrumb_custom]

Tag: PTPI Stock
Stock

Petros Pharmaceuticals Inc: Weathering Stock Market Storms with 5.16M Market Cap

Petros Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $9.54 on 04/20/23 and a low of $0.74 for the same time frame on 04/15/24. 52-week price history of PTPI Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Petros Pharmaceuticals Inc’s current trading price is -92.14% away from its 52-week high, while its distance from the 52-week low is 1.58%. The stock’s price range during the 52-week period has remained between $0.74 and $9.54. In

DOYU
Industry

Petros Pharmaceuticals Inc Inc. (PTPI) Price Performance: A Technical Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -24.11%. However, over the last six months, the performance has been stronger by -38.15%. The price of PTPI decreased -35.93% over the last 30 days. And in the last five days, it has fallen by -31.85%. Petros Pharmaceuticals Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $9.54 on 04/20/23, and the lowest price
News

Petros Pharmaceuticals Inc (PTPI) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Petros Pharmaceuticals Inc’s current trading price is -84.80% away from its 52-week high, while its distance from the 52-week low is 58.09%. The stock’s price range over this period has fluctuated between $0.92 and $9.54. The company, operating within the financial sector, had a trading volume of approximately 0.74 million for the day, which was noticeably lower than the average daily share volume of 1.06 million over the last 3 months. Petros Pharmaceuticals Inc’s market performance has

THMO
News

Petros Pharmaceuticals Inc (PTPI) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Petros Pharmaceuticals Inc’s current trading price is -83.44% away from its 52-week high, while its distance from the 52-week low is 72.26%. The stock’s price range for this time frame has been between $0.92 and $9.54. The trading volume of the company’s shares in the Healthcare reached around 3.8 million for the day, which was evidently higher than the average daily volume of 0.95 million over the last three months. In terms of market performance, Petros Pharmaceuticals Inc had
Market Activity

Petros Pharmaceuticals, Inc. (PTPI) Stock Surging in Premarket Trading Session

Petros Pharmaceuticals, Inc. (PTPI), a pharmaceutical company, has surged 7.83% in the premarket trading session and consequently is trading at $1.79 at the time of the writing. On Thursday, the stock closed the day at $1.66 after sliding by 9.29% during the regular trading session. The last press release from the company was regarding the launch of studies for STENDRA. PTPI Initiated Self-Selection Studies On Tuesday, PTPI announced that it had initiated the two self-selection studies for its erectile dysfunction (ED) drug STENDRA® (avanafil). The company said that the results of eh study would be part of a comprehensive data package that

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne